Peng Jinyong, Xu Qiwei, Xu Youwei, Qi Yan, Han Xu, Xu Lina
School of Pharmacy, Dalian Medical University, Dalian 116027, China.
Nat Prod Res. 2007 Jun;21(7):641-5. doi: 10.1080/14786410701371165.
A new dihydroflavanoid was obtained from the root of Spiranthes australis (R. Brown) Lindl, a traditional Chinese medicinal herb. The structure was elucidated as (2S)-5,2',6'-trihydroxy-6-lavandulyl-4''-(gamma,gamma-dimethylallyl)-2'',2''-dimethylpyrano-[5'',6'' : 7,8]-flavanone by spectroscopic methods including UV, IR, HR-EI-MS, ESI-MS, 1D NMR and 2D NMR techniques, and subsequently, the anticancer activities of the compound to inhibit human cancer cells' growth including A549, BEL-7402, SGC-7901, MCF-7, HT-29, K562, and A498 cell lines by MTT method was evaluated in vitro.
从传统中草药澳洲绶草(Spiranthes australis (R. Brown) Lindl)的根部获得了一种新的二氢黄酮类化合物。通过紫外光谱(UV)、红外光谱(IR)、高分辨电子轰击质谱(HR-EI-MS)、电喷雾电离质谱(ESI-MS)、一维核磁共振(1D NMR)和二维核磁共振(2D NMR)等光谱方法确定其结构为(2S)-5,2',6'-三羟基-6-薰衣草基-4''-(γ,γ-二甲基烯丙基)-2'',2''-二甲基吡喃并-[5'',6'' : 7,8]-黄烷酮,随后,采用MTT法在体外评估了该化合物对人癌细胞系A549、BEL-7402、SGC-7901、MCF-7、HT-29、K562和A498生长的抑制抗癌活性。